Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma Completed Phase 2 Trials for Ceritinib (DB09063)

IndicationStatusPhase
DBCOND0080806 (Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02276027A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung CancerTreatment